AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year

Go back to AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year

Jefferies Reiterates Bullish View on Abbvie (ABBV) Amid 'Double Dose' of Good News

September 7, 2017 1:06 PM EDT

Jefferies analyst Jeffrey Holford reiterated a Buy rating and $94 price target on Abbvie (NYSE: ABBV) citing a double dose of good news.

Holford highlighted '619 IPR victory and strong PII data for ABT-494 in AD

For an analyst ratings summary and... More